Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02530073 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

Study acronym: FETO
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv9
  2. Secondary endpoints: 2 to 4
    • Study site revised
    • Study title expanded, about 2 words
    v8
  3. Lead sponsor: Medical City Children's Hospital to Connecticut Children's Medical Center
    • Primary completion date: Aug 2022 to Aug 2028
    • Study completion date: Feb 2023 to Aug 2030
    v7
  4. Re-verified, no change to tracked fieldsv6
  5. Lead sponsor: University of Colorado, Denver to Medical City Children's Hospital
    • Eligibility criteria revised
    • Study site revised
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. 2 versions Re-verified since Aug 22, 2016, no change to tracked fieldsv3-v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore adequate lung growth for neonatal survival.
Trial Details
NCT Number NCT02530073
Lead Sponsor Connecticut Children's Medical Center
Conditions
(from sponsor)		 Congenital Diaphragmatic Hernias
Related terms Hernias, Diaphragmatic, Congenital
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov